<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Qingdao Haier Biomedical Co Ltd — News on 6ix</title>
    <link>https://6ix.com/company/qingdao-haier-biomedical-co-ltd</link>
    <description>Latest news and press releases for Qingdao Haier Biomedical Co Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 30 Apr 2026 04:27:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/qingdao-haier-biomedical-co-ltd" rel="self" type="application/rss+xml" />
    <item>
      <title>Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025</title>
      <link>https://6ix.com/company/qingdao-haier-biomedical-co-ltd/news/haier-biomedical-drives-global-leap-of-life-science-infrastructure-international-business-hits-record-high-for-36percent-of-annual-revenue-in-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/qingdao-haier-biomedical-co-ltd/news/haier-biomedical-drives-global-leap-of-life-science-infrastructure-international-business-hits-record-high-for-36percent-of-annual-revenue-in-2025</guid>
      <pubDate>Thu, 30 Apr 2026 04:27:00 GMT</pubDate>
      <description>Haier Biomedical (688139.SH), a global leader in life sciences and medical solutions, has officially published its 2025 annual report, posting full‑year revenue of 2.33 billion yuan (USD 340.77 million) with overseas revenue growing 17.9% year-on-year to 840 million yuan (USD 122.85 million), accounting for 36% of total revenue – a record high. Despite a complex global trade environment, Haier Biomedical delivered double‑digit growth across all international business sectors.</description>
    </item>
  </channel>
</rss>